Deputy Assistant Administrator in the Office of Diversion Control, Drug Enforcement Agency Joseph T. Rannazzisi will be the key not speaker. Speakers will focus on KASPER, Pill Mill law, pain management facilities, controlled substance guidance, adherence monitoring and documentation, according to the report.
More Articles on Pain Management:
NeuroMetrix Receives FDA 510(k) Clearance for Electrical Nerve Stimulator
Central Phoenix Surgical Center Adds Progenitor Cell Therapy
Indiana Senator to Sponsor Bill Requiring Pain Clinic Owners to be Physicians
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
